QurieGen
Utilizing a high-throughput proprietary approach for mapping cellular responses, combined with single-cell genomics and data science, to craft predictive models of disease biology and drug response.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | €2.2m | Seed | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads